You have no items in your shopping cart.
Search results for: 'TGF'
Biotinylated Mouse Latent TGF-beta 1 (N-8His-Avi) [orb2993080]Predicted: 12.8&31.7 KDa. Observed: 13&35-45 KDa, reducing conditions
100 μg, 20 μgPredicted: 12.8&31.4 KDa. Observed: 11&35-45 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Mouse Latent TGF-beta 1 (N-8His) [orb2993082]
Predicted: 12.8&31.7 KDa. Observed: 12&35-45 KDa , reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Biotinylated Human TGF-beta 2 (N-Avi) [orb2993087]
Predicted: 14.5 KDa. Observed: 10-14 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human TGF-beta 3 (N-Avi) [orb2993088]
Predicted: 14.5 KDa. Observed: 10-14 KDa, reducing conditions
100 μg, 20 μg - Recombinant Mouse TGFBR1 (C-Fc) [orb2993858]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.6 KDa. Observed: 40-60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Mouse TGFBR3 (C-6His) [orb2993821]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 85.9 KDa. Observed: 110-125 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Mouse TGFBR2 (C-Fc) [orb2993827]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45 KDa. Observed: 60-75 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human LAP (TGF-beta 1) [orb2993832]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.5 KDa. Observed: 20-30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human GFRA1 (C-Fc) [orb2993981]
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 72.4 KDa. Observed: 85 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg